Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in life-sciences, but cautioned that full-year sales would come in at the ...

Merck KGaA offers investors strong fundamentals and diverse business segments in healthcare, life sciences, and electronics. Read more here.

Germany’s Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced research and development expenses in its healthcare segment and ...

Germany’s Merck MRK-0.53%decrease; red down pointing triangle KGaA shares dropped after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

Germany's Merck KGaA on Monday said it aims to double the productivity of its research and development into oncology, neurology and immunology treatments.

Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and uncertainty around global tariffs. The stock tumbled.

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

The definitive agreement between Merck KGaA, Darmstadt, Germany and SpringWorks, based in Stamford, Connecticut, was announced on 28 April, 2025. It represents one of the biggest M&A deals in the ...

For example, the Merck KGaA(ETR:MRK) share price is up 39% in the last five years, slightly above the market return. In comparison, the share price is down 13% in a year.

(RTTNews) - Shares of Merck KgaA (MKGAY.PK) were losing more than 14 percent in the early morning trading in Germany after the science and technology major said its two Phase III EVOLUTION ...